AxoGen Financial Statements (AXGN)
|
|
|
|
Report date
|
|
|
25.02.2022 |
30.09.2022 |
14.03.2023 |
01.05.2023 |
05.03.2024 |
|
07.11.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
127.4 |
|
138.6 |
138.6 |
159.0 |
|
180.9 |
|
Operating Income, bln rub |
|
|
-25.4 |
|
-29.7 |
-29.7 |
-21.5 |
|
-8.50 |
|
EBITDA, bln rub |
? |
|
-20.9 |
|
-25.1 |
-23.5 |
-13.3 |
|
1.02 |
|
Net profit, bln rub |
? |
|
-28.1 |
|
-27.3 |
-27.3 |
-21.7 |
|
-14.3 |
|
|
OCF, bln rub |
? |
|
-13.4 |
|
-16.1 |
-16.1 |
-5.72 |
|
-4.41 |
|
CAPEX, bln rub |
? |
|
28.4 |
|
21.3 |
21.3 |
14.9 |
|
4.49 |
|
FCF, bln rub |
? |
|
-41.8 |
|
-37.3 |
-37.3 |
-20.6 |
|
-8.62 |
|
Dividend payout, bln rub
|
|
|
0.000 |
|
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
|
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
129.8 |
|
144.1 |
144.1 |
149.3 |
|
146.7 |
|
Cost of production, bln rub |
|
|
22.9 |
|
24.1 |
24.1 |
31.1 |
|
42.7 |
|
R&D, bln rub |
|
|
24.2 |
|
27.2 |
27.2 |
28.3 |
|
28.4 |
|
Interest expenses, bln rub |
|
|
1.36 |
|
0.624 |
0.624 |
2.84 |
|
8.29 |
|
|
Assets, bln rub |
|
|
208.0 |
195.5 |
195.4 |
195.4 |
196.8 |
|
192.0 |
|
Net Assets, bln rub |
? |
|
112.6 |
101.4 |
101.0 |
101.0 |
95.7 |
|
99.4 |
|
Debt, bln rub |
|
|
67.5 |
67.7 |
67.4 |
67.4 |
69.3 |
|
68.9 |
|
Cash, bln rub |
|
|
84.1 |
53.1 |
48.8 |
48.8 |
37.0 |
|
18.7 |
|
Net debt, bln rub |
|
|
-16.6 |
14.5 |
18.6 |
18.6 |
32.3 |
|
50.2 |
|
|
Ordinary share price, rub |
|
|
9.37 |
11.9 |
9.98 |
9.98 |
6.83 |
|
3.79 |
|
Number of ordinary shares, mln |
|
|
41.2 |
|
42.1 |
42.1 |
42.9 |
|
43.9 |
|
|
Market cap, bln rub |
|
|
386 |
0 |
420 |
420 |
293 |
|
166 |
|
EV, bln rub |
? |
|
370 |
15 |
439 |
439 |
325 |
|
217 |
|
Book value, bln rub |
|
|
110 |
98 |
97 |
97 |
91 |
|
94 |
|
|
EPS, rub |
? |
|
-0.68 |
|
-0.65 |
-0.65 |
-0.51 |
|
-0.33 |
|
FCF/share, rub |
|
|
-1.01 |
|
-0.89 |
-0.89 |
-0.48 |
|
-0.20 |
|
BV/share, rub |
|
|
2.66 |
|
2.31 |
2.31 |
2.13 |
|
2.15 |
|
|
EBITDA margin, % |
? |
|
-16.4% |
|
-18.1% |
-16.9% |
-8.38% |
|
0.57% |
|
Net margin, % |
? |
|
-22.0% |
|
-19.7% |
-19.7% |
-13.7% |
|
-7.91% |
|
FCF yield, % |
? |
|
-10.8% |
0.00% |
-8.89% |
-8.89% |
-7.05% |
|
-5.18% |
|
ROE, % |
? |
|
-24.9% |
0.00% |
-27.1% |
-27.1% |
-22.7% |
|
-14.4% |
|
ROA, % |
? |
|
-13.5% |
0.00% |
-14.0% |
-14.0% |
-11.0% |
|
-7.45% |
|
|
P/E |
? |
|
-13.8 |
|
-15.4 |
-15.4 |
-13.5 |
|
-11.6 |
|
P/FCF |
|
|
-9.24 |
|
-11.3 |
-11.3 |
-14.2 |
|
-19.3 |
|
P/S |
? |
|
3.03 |
|
3.03 |
3.03 |
1.84 |
|
0.92 |
|
P/BV |
? |
|
3.52 |
0.00 |
4.31 |
4.31 |
3.21 |
|
1.77 |
|
EV/EBITDA |
? |
|
-17.7 |
|
-17.5 |
-18.7 |
-24.4 |
|
211.6 |
|
Debt/EBITDA |
|
|
0.80 |
|
-0.74 |
-0.79 |
-2.42 |
|
49.1 |
|
|
R&D/CAPEX, % |
|
|
85.1% |
|
127.8% |
127.8% |
189.9% |
|
631.4% |
|
|
CAPEX/Revenue, % |
|
|
22.3% |
|
15.3% |
15.3% |
9.38% |
|
2.48% |
|
| AxoGen shareholders |
